UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4862-4869

2012

Link zum Volltext

Verfügbarkeit prüfen

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

Journal of clinical microbiology, 2018-02, Vol.56 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7601-7605

2014

Link zum Volltext

Verfügbarkeit prüfen

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3528-3535

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3395-3398

2012

Link zum Volltext

Verfügbarkeit prüfen

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6361-6365

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.1195-1199

2014

Link zum Volltext

Verfügbarkeit prüfen

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Link zum Volltext

Verfügbarkeit prüfen

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections

Clinical infectious diseases, 2016-12, Vol.63 (12), p.1615-1618

2016

Link zum Volltext

Verfügbarkeit prüfen

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

Clinical infectious diseases, 2017-07, Vol.65 (1), p.110-120

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5793-5797

2015

Link zum Volltext

Verfügbarkeit prüfen

Five-Minute Exposure to Caspofungin Results in Prolonged Postantifungal Effects and Eliminates the Paradoxical Growth of Candida albicans

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3598-3602

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3227-3231

2016

Link zum Volltext

Verfügbarkeit prüfen

Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3187-3192

2016

Link zum Volltext

Verfügbarkeit prüfen

Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6573-6577

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of Candida Real-time Polymerase Chain Reaction, β-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

Clinical infectious diseases, 2012-05, Vol.54 (9), p.1240-1248

2012

Link zum Volltext

Verfügbarkeit prüfen

Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4443-4451

2014

Link zum Volltext

Verfügbarkeit prüfen

Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens

Clinical infectious diseases, 2017-09, Vol.65 (5), p.738-745

2017

Link zum Volltext

Verfügbarkeit prüfen

Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection

Antimicrobial agents and chemotherapy, 2015-12, Vol.59 (12), p.7465-7470

2015

Link zum Volltext

Verfügbarkeit prüfen

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature

Open forum infectious diseases, 2017-07, Vol.4 (3), p.ofx101-ofx101

2017

Link zum Volltext

Verfügbarkeit prüfen

Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1797-1801

2015

Link zum Volltext

Verfügbarkeit prüfen

KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7597-7600

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(41)
Bücher
(14)

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Microbiology
(25)
Humans
(21)
Pharmacology & Pharmacy
(18)
Microbial Sensitivity Tests
(17)
Biological And Medical Sciences
(12)
Female
(12)
Male
(12)
Medical Sciences
(12)
Middle Aged
(11)
Aged
(10)
Klebsiella Pneumoniae
(10)
Adult
(9)
Anti-Bacterial Agents
(9)
Anti-Bacterial Agents - Pharmacology
(9)
Klebsiella Pneumoniae - Drug Effects
(9)
Pharmacology. Drug Treatments
(9)
Susceptibility
(9)
Mutation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases

Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae

Five-Minute Exposure to Caspofungin Results in Prolonged Postantifungal Effects and Eliminates the Paradoxical Growth of Candida albicans

Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates

Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae

Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata

Performance of Candida Real-time Polymerase Chain Reaction, β-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents

Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens

Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature

Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia

KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistance to amikacin

Suchergebnisse filtern